Pulmonary Tuberculosis V
Pulmonary Tuberculosis IV
Pulmonary Tuberculosis III
Therapeutic Drug Monitoring: Affecting Factors
Pulmonary Tuberculosis I
Pulmonary Tuberculosis II
You might also read
Articles linked to this work by shared authors, journal, and citation graph.
Updated: May 2, 2026

Author Spotlight: Optimizing CFU Determination for Efficient Assessment of TB Vaccine Efficacy and Antigen Presentation Analysis
Published on: July 28, 2023
Giovanni Battista Migliori1, Giovanni Sotgiu2
1WHO Collaborating Centre for Tuberculosis and Lung Diseases, Fondazione S Maugeri, Care and Research Institute, Tradate 21049, Italy.
No abstract available in PubMed .